Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

real-time data

Sanofi reception

Sanofi cuts forecasts but says worst effects of patent cliff have passed

Sales continue to fall on generic competition and mismanagement in Brazil affects emerging markets

- PMLiVE

AZ inks $815m deal for FibroGen anaemia drug

Deal comes as company reveals second quarter performance

Actelion HQ Switzerland

Actelion to buy Ceptaris – if FDA backs its cancer treatment

Acquisition contingent on Valchlor approval in rare lymphoma

BTG extends orphan drug distribution partnership with Clinigen

Deal covers treatment for overexposure to chemotherapy

- PMLiVE

Executive changes at Sanofi

Genzyme CEO Meeker becomes executive VP and Hellmann joins to lead animal health

iPad detailing: still room for pharma to improve

Doctors want to be 'wowed', and video is where iPads shine, says Manhattan Research

- PMLiVE

Have you got the adaptability factor?

Do you need an ‘adaptability gene’ to relish working in today’s multi-media brand communications?

- PMLiVE

Pfizer sales dip as net income surges in Q2

Lipitor performance weighs heavy on the figures

- PMLiVE

Merck profit slides as generics continue to bite

Singulair, Maxalt, Cozaar and Clarinex sales all affected

- PMLiVE

UCB’s Steve Arnold joins ABPI board

Will work to support life sciences in the UK

- PMLiVE

UK court upholds Teva’s patent on Copaxone

Dismisses challenge from Mylan

FDA grants priority review to pain drug

Mallinckrodt’s MNK-795 is intended for the management of moderate to severe acute pain

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links